Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

About this Publication
Title
Pathology image-based predictive model for individual survival time of early-stage lung adenocarcinoma patients.
Pubmed ID
41093883 (View this publication on the PubMed website)
Digital Object Identifier
Publication
Sci Rep. 2025 Oct 15; Volume 15 (Issue 1): Pages 35964
Authors
Vo VT, Yang HJ, Lee T, Kim SH
Affiliations
  • Department of Artificial Intelligence Convergence, Chonnam National University, Gwangju, 61186, South Korea.
  • Department of Pathology, Chonnam National University Medical School, Gwangju, 61186, South Korea. dr.taebum@gmail.com.
  • Department of Artificial Intelligence Convergence, Chonnam National University, Gwangju, 61186, South Korea. shkim@jnu.ac.kr.
Abstract

The tumor microenvironment (TME) is associated with tumor prognosis, immunotherapy response, and prognosis in patients. Here, we hypothesized that the entire TME in pathology image is associated with the survival time prediction. To address this hypothesis, we utilize the entire TME on pathology image of early-stage lung adenocarcinoma (esLUAD), which is the most common histological subtype of lung cancer. Notably, we investigated whether machine learning models can predict individual survival time from pathology images without region-level annotation and solely based on patient-level survival data. In particular, we proposed a pathology image-based predictive model in a cascaded learning system to predict the individual survival time of esLUAD patients in two independent cohorts (National Lung Screening Trial (NLST) and Cancer Genome Atlas Program (TCGA)). Besides that, we estimate a mean absolute error (MAE) score and a C-index score that are strongly associated with the survival time prediction. Our method achieved (361.90 MAE - 0.70 C-index) and (365.67 MAE - 0.58 C-index) in early-stage NLST and early-stage TCGA cohorts, respectively. Together, the presented results highlight the importance of computation pathology algorithms in predicting survival time using the entire TME information in pathology images and support the use of computational methods to improve the efficiency of clinical trial studies.

Related CDAS Studies
Related CDAS Projects